Drug Profile
Acoziborole - Drugs for Neglected Diseases Initiative Foundation
Alternative Names: AN-5568; Oxaborole SCYX-7158; SCYX-7158Latest Information Update: 13 Apr 2024
Price :
$50
*
At a glance
- Originator Anacor Pharmaceuticals; SCYNEXIS
- Developer Drugs for Neglected Diseases Initiative Foundation
- Class Antiprotozoals; Benzamides; Organic boron compounds; Small molecules
- Mechanism of Action Protein biosynthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II/III African trypanosomiasis
Most Recent Events
- 08 Apr 2024 Drugs for Neglected Diseases plans a phase III trial for African trypanosomiasis (In adolescents, In adults, In the elderly) (PO, Tablets) (NCT06356974),
- 03 May 2023 Drugs for Neglected Diseases completes phase-I trial in African trypanosomiasis (In volunteers, In adults) in Malaysia (PO) (NCT05947604)
- 09 Feb 2023 Phase-I clinical trials in African trypanosomiasis (In volunteers, In adults) in Malaysia (PO) (NCT05947604) 700365758